Amneal Pharmaceuticals, Inc. (AMRX) Social Stream
AMNEAL PHARMACEUTICALS INC (AMRX) Price Targets From Analysts
Use the tables below to see what analysts covering AMNEAL PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 7 | $8 | $5 | $6.3 | $2.39 | 163.6% |
| 2022-03-22 | 5 | $8 | $5 | $6.666 | $2.39 | 178.91% |
| 2022-05-23 | 4 | $8 | $7 | $7.333 | $2.39 | 206.82% |
| 2022-08-01 | 4 | $8 | $6 | $7 | $2.39 | 192.89% |
| 2022-08-19 | 5 | $7 | $4 | $6 | $2.39 | 151.05% |
| 2022-11-02 | 3 | $7 | $4 | $5.75 | $2.39 | 140.59% |
| 2022-11-04 | 5 | $7 | $4 | $5.25 | $2.39 | 119.67% |
The Trend in the Analyst Price Target
AMRX's average price target has moved up $0.69 over the prior 26 months.
Over the past 35 weeks, AMRX's average upside potential has been 110.55%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-02 | 5 | 8 | 5 | 6.666 | 4.02 | 65.82% |
| 2022-03-22 | 4 | 8 | 5 | 6.666 | 4.04 | 65% |
| 2022-08-01 | 4 | 8 | 6 | 7.000 | 3.54 | 97.74% |
| 2022-08-08 | 5 | 7 | 4 | 6.000 | 3.13 | 91.69% |
| 2022-11-04 | 5 | 7 | 4 | 5.250 | 2.12 | 147.64% |
AMRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.2 | 3 | 0 | 1 | 1 | 1 | 5 |
The Trend in the Broker Recommendations
Over the past 29 months, AMRX's average broker recommendation rating improved by 1.32.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- AMRX has a higher average analyst price target than 76.94% of all US stocks.
- AMNEAL PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1221.45% of stocks in the mid market cap category.
- In terms of how AMNEAL PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 288.28% of that group.
- AMRX has a lower variance in analysts' estimates than -299.55% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AMNEAL PHARMACEUTICALS INC are MOR, RCUS, and APLS.
View All Top Stocks by Price Target
Is AMRX a Buy, Hold or Sell? See the POWR Ratings now!